Table 1.
Genes conferring susceptibility to naevi and/or melanoma.
| Gene | Nevus count GWAS p-value | Melanoma GWAS p-value |
|---|---|---|
| Low to medium penetrance (38, 43) | ||
| ASIP | 0.215 | 8.36 × 10−25 |
| ATM | 0.006 | 1.38 × 10−12 |
| CASP8 | 0.134 | 8.88 × 10−09 |
| CDKAL1 | 0.351 | 3.27 × 10−08 |
| CYP1B1 | 5.70 × 10−07 | 2.40 × 10−05 |
| DOCK8 | 1.95 × 10−08 | 5.52 × 10−06 |
| FAM208B | 1.95 × 10−08 | 5.52 × 10−06 |
| FMN1 | 6.52 × 10−06 | 1.43 × 10−06 |
| FTO | 0.014 | 1.81 × 10−09 |
| GPRC5A | 5.72 × 10−06 | 4.08 × 10−07 |
| HDAC4 | 7.59 × 10−07 | 2.16 × 10−04 |
| IRF4 | 4.21 × 10−67 | 8.22 × 10−01 |
| KITLG | 8.40 × 10−09 | 6.61 × 10−01 |
| MC1R | 0.067 | 6.24 × 10−92 |
| MITF (2) | 5 × 10−4 | 2 × 10−18 |
| MTAP rs869329 | 2.12 × 10−37 | 1.14 × 10−31 |
| MTAP rs11532907 | 2.30 × 10−17 | 1.42 × 10−19 |
| MX2 | 0.063 | 3.28 × 10−15 |
| NFIC | 2.22 × 10−04 | 1.02 × 10−05 |
| OCA2 | 0.935 | 3.11 × 10−09 |
| PARP1 | 0.004 | 3.59 × 10−13 |
| PLA2G6 rs132985 | 3.06 × 10−18 | 4.76 × 10−12 |
| PLA2G6 rs2005974 | 3.31 × 10−14 | 7.83 × 10−11 |
| PPARGC1B | 4.71 × 10−07 | 4.58 × 10−04 |
| SETDB1 | 0.007 | 3.88 × 10−12 |
| SLC45A2 | 0.755 | 2.30 × 10−12 |
| SYNE2 | 1.95 × 10−04 | 1.74 × 10−05 |
| TCONS_12_00025686 | 0.002 | 1.84 × 10−09 |
| TERC | 5.73 × 10−06 | 1.64 × 10−05 |
| TERT | 0.003 | 1.66 × 10–17 |
| TPCN2/CCND1 | 0.209 | 1.01 × 10−10 |
| TTC7B | 0.415 | 4.63 × 10−14 |
| TYR | 0.605 | 1.01 × 10−26 |
| 9q31 region | 1.35 × 10−04 | 2.30 × 10−08 |
| High-penetrance familial melanoma (44) | ||
| ACD | + | |
| ACH | + | |
| BAP1 | + | |
| CDK4 | + | |
| CDKN2A | + | + |
| EBF3* | + | |
| GOLM1* | + | |
| NEK11* | + | |
| POLE* | + | |
| POT1 | + | |
| TERF2IP | + | |
| TERT | + | + |
Proposed high-penetrance melanoma genes; further research to confirm these is ongoing.
Indicates association.